Evommune Licenses EVO570 From Hinova for $30 Million Upfront
Evommune agreed to license EVO570 from Hinova for $30 million upfront.
Related stories
Nikkei Futures Rise 1.2% to 63,195 on SGX
Japanese stocks may rise after oil fell sharply. The dollar was at 158.39 yen.
M impact | EQUITY | Nov 04, 2026, 11:44 PM UTC
Qualcomm shares slide as smartphone weakness clouds growth outlook
Qualcomm shares fell, while handset revenue declined 26%. The report says smartphone weakness clouded the company's growth push.
H impact | EQUITY | Nov 04, 2026, 11:39 PM UTC
US Stock Indices Rise; S&P 500 Gains 2%, Nasdaq 100 1%
U.S. indices ended higher Wednesday: the S&P 500 rose 2% and the Nasdaq 100 gained 1%.
M impact | EQUITY | Nov 04, 2026, 11:33 PM UTC
Global market picture: S&P 500 +1.76%, Nasdaq 100 +0.96%; EUR/USD +0.4%, WTI -8.35%
Global market picture. US index futures: S and P futures is up 1.76 percent, Nasdaq futures is up 0.96 percent, Dow futures is up 3.26 percent and Russell futures is up 1.65 percen
M impact | EQUITY | Nov 04, 2026, 11:31 PM UTC
BNY Plans Investment Firm Merger for January 2027
BNY plans to merge investment firms into BNY Investments Corporation in January 2027.
M impact | EQUITY | Nov 04, 2026, 11:30 PM UTC
Datadog Publishes Q3 2026 Earnings Call Transcript
Datadog published a transcript of its Q3 2026 earnings call.
M impact | EQUITY | Nov 04, 2026, 11:28 PM UTC